The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Mendelson Daniel Newman since 2014.
This trader's CIK number is 1327897.
At the time of last reporting, Mendelson Daniel Newman was the Director of Champions Oncology, Inc.. (stock ticker symbol CSBR).
Also see all insider trading activities at Champions Oncology, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2024 | CSBR | 15,444 | $95,971 | 0 | $0 | 0 | $0 |
| 2023 | CSBR | 60,060 | $345,797 | 0 | $0 | 0 | $0 |
| 2020 | CSBR | 1,246 | $7,402 | 0 | $0 | 64,375 | $300,600 |
| 2018 | CSBR | 0 | $0 | 13,333 | $177,245 | 0 | $0 |
| 2015 | CSBR | 750,000 | $0 | 0 | $0 | 0 | $0 |
| 2014 | CSBR | 100,000 | $107,920 | 0 | $0 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2024-01-12 | CSBR | Buy | 1,000 | 6.50 | 6,500 |
| 2024-01-11 | CSBR | Buy | 2,000 | 6.27 | 12,540 |
| 2024-01-10 | CSBR | Buy | 2,944 | 6.31 | 18,576 |
| 2024-01-09 | CSBR | Buy | 3,000 | 6.25 | 18,750 |
| 2024-01-08 | CSBR | Buy | 1,000 | 6.15 | 6,150 |
| 2024-01-05 | CSBR | Buy | 2,000 | 6.09 | 12,180 |
| 2024-01-04 | CSBR | Buy | 3,000 | 6.12 | 18,360 |
| 2024-01-03 | CSBR | Buy | 500 | 5.83 | 2,915 |
| 2023-12-21 | CSBR | Buy | 2,500 | 4.92 | 12,300 |
| 2023-12-20 | CSBR | Buy | 2,100 | 4.82 | 10,122 |
| 2023-12-19 | CSBR | Buy | 5,000 | 4.75 | 23,750 |
| 2023-09-29 | CSBR | Buy | 4,000 | 6.16 | 24,640 |
| 2023-09-27 | CSBR | Buy | 1,500 | 5.95 | 8,925 |
| 2023-09-28 | CSBR | Buy | 5,000 | 6.22 | 31,100 |
| 2023-10-11 | CSBR | Buy | 5,000 | 6.40 | 32,000 |
| 2023-10-10 | CSBR | Buy | 1,100 | 6.41 | 7,051 |
| 2023-10-06 | CSBR | Buy | 1,530 | 6.48 | 9,914 |
| 2023-10-05 | CSBR | Buy | 2,000 | 6.47 | 12,940 |
| 2023-10-04 | CSBR | Buy | 5,000 | 6.40 | 32,000 |
| 2023-10-03 | CSBR | Buy | 2,500 | 6.30 | 15,750 |
| 2023-09-26 | CSBR | Buy | 5,000 | 5.65 | 28,250 |
| 2023-09-22 | CSBR | Buy | 3,812 | 5.50 | 20,966 |
| 2023-09-21 | CSBR | Buy | 5,000 | 5.51 | 27,550 |
| 2023-09-20 | CSBR | Buy | 4,018 | 5.51 | 22,139 |
| 2023-09-19 | CSBR | Buy | 5,000 | 5.28 | 26,400 |
| 2020-02-11 | CSBR | Option Ex | 34,375 | 5.76 | 198,000 |
| 2020-02-18 | CSBR | Option Ex | 30,000 | 3.42 | 102,600 |
| 2020-03-26 | CSBR | Buy | 1,220 | 5.95 | 7,259 |
| 2020-03-24 | CSBR | Buy | 26 | 5.50 | 143 |
| 2018-11-06 | CSBR | Sale | 5,000 | 13.75 | 68,750 |
| 2018-09-20 | CSBR | Sale | 8,333 | 13.02 | 108,495 |
| 2015-03-11 | CSBR | Buy | 750,000 | .00 | 0 |
| 2014-03-19 | CSBR | Buy | 2,500 | 1.05 | 2,620 |
| 2014-03-20 | CSBR | Buy | 97,500 | 1.08 | 105,300 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Mendelson Daniel Newman (Director of Champions Oncology, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.